Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels.
Ethanol treatment of cultured hepatoma cells and of mice inhibited the activity of AMP-activated protein kinase (AMPK). This study shows that the inhibitory effect of ethanol on AMPK phosphorylation is exerted through the inhibition of the phosphorylation of upstream kinases and the activation of protein phosphatase 2A (PP2A).Inhibition of AMPK phosphorylation by palmitate was attributed to ceramide-dependent PP2A activation. We hypothesized that the inhibitory effect of ethanol on AMPK phosphorylation was mediated partly through the generation of ceramide. The effect of ethanol and inhibitors of ceramide synthesis on AMPK phosphorylation, ceramide levels, and PP2A activity were assessed in rat hepatoma cells (H4IIEC3). The effect of ethanol on hepatic ceramide levels was also studied in C57BL/6J mice fed the Lieber-DeCarli diet. In H4IIEC3 cells, ceramide reduced AMPK phosphorylation when they were treated for between 4 and 12 h. The basal level of AMPK phosphorylation in hepatoma cells was increased with the treatment of ceramide synthase inhibitor, fumonisin B1. Ethanol treatment significantly increased cellular ceramide content and PP2A activity by approximately 18-23%, when the cells were treated with ethanol for between 4 and 12 h. These changes in intracellular ceramide concentrations and PP2A activity correlated with the time course over which ethanol inhibited AMPK phosphorylation. The activation of PP2A and inhibition of AMPK phosphorylation caused by ethanol was attenuated by fumonisin B1 and imipramine, an acid sphingomyelinase (SMase) inhibitor. There was a significant increase in the levels of ceramide and acid SMase mRNA in the livers of ethanol-fed mice compared with controls. We concluded that the effect of ethanol on AMPK appears to be mediated in part through increased cellular levels of ceramide and activation of PP2A.
Departments of 1Medicine, Indiana University School of Medicine, Indianapolis, Indiana. sliangpu@iupui.edu
Suthat
S
Liangpunsakul
Margaret S
MS
Sozio
Eric
E
Shin
Zhenwen
Z
Zhao
Yan
Y
Xu
Ruth A
RA
Ross
Yan
Y
Zeng
David W
DW
Crabb
D000263:Adenylate Kinase / Q000378:metabolism*; D000814:Aniline Compounds; D000818:Animals; D001597:Benzylidene Compounds; D002460:Cell Line; D002518:Ceramides / Q000378:metabolism*; D004032:Diet; D000431:Ethanol / Q000633:toxicity*; D005229:Fatty Acids, Monounsaturated; D037341:Fumonisins; D005786:Gene Expression Regulation / Q000187:drug effects; D006861:Hydrogen Peroxide; D007099:Imipramine; D008297:Male; D051379:Mice; D010766:Phosphorylation; D054648:Protein Phosphatase 2 / Q000235:genetics / Q000378:metabolism; D051381:Rats
D000814:Aniline Compounds; D001597:Benzylidene Compounds; D002518:Ceramides; D005229:Fatty Acids, Monounsaturated; D037341:Fumonisins; C468773:GW 4869; D000431:Ethanol; C056933:fumonisin B1; D006861:Hydrogen Peroxide; D000263:Adenylate Kinase; D054648:Protein Phosphatase 2; D007099:Imipramine; C001996:thermozymocidin